Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The contribution of fungal infections to the morbidity and mortality of HIV-infected individuals is largely unrecognized. A recent meeting highlighted several priorities that need to be urgently addressed, including improved epidemiological surveillance, increased availability of existing diagnostics and drugs, more training in the field of medical mycology, and better funding for research and provision of treatment, particularly in developing countries.

Original publication

DOI

10.1016/j.tim.2013.12.008

Type

Journal article

Journal

Trends Microbiol

Publication Date

03/2014

Volume

22

Pages

107 - 109

Keywords

AIDS, HIV, fungal infection, immunity, mortality, translational research, AIDS-Related Opportunistic Infections, Acquired Immunodeficiency Syndrome, Antifungal Agents, Humans, Mycoses